Office Action 1: Non-Final Rejection (2024-06-27)
Rejection types: Double Patenting

CLAIMS:
WHAT IS CLAIMED IS:

1\. A method of manufacturing a multi-ply, creped and embossed tissue product comprising the steps of:a. providing a first tissue web having a first outer surface and a second outer surface;
b. providing a heated creping surface;
c. applying a latex emulsion comprising a non-crosslinked vinyl acetate-ethylene polymer to at least the first outer surface of the first tissue web to yield a latex treated tissue web;
d. adhering the latex treated tissue web to the heated creping surface;
e. contacting the adhered tissue web with a creping blade to remove the adhered tissue web from the heated creping surface and yield a creped tissue ply;
f. conveying two or more creped tissue plies through an embossing-laminating device to yield a multi-ply, creped and embossed tissue product having a geometric mean tensile strength (GMT) from 700 to 1,700 g/3", a Durability Index from 10.0 to 18.0 and a Slosh time from 10 seconds to 2 minutes.

2\. The method of claim 1further comprising the step of applying a softening composition to the outer surface of at least one creped tissue ply, wherein the softening composition is selected from the group consisting of a polyhydroxy compound having a molecular weight of at least about 1,000 g/mol, a diamidoamine quaternary compound, an ester quaternary compound, an alkoxy alkyl quaternary compound, a benzyl quaternary compound, an alkyl quaternary compound, an imidazolinium quaternary compounds, a polysiloxane and glycerin.

3\. The method of claim 1wherein the latex emulsion further an anti-blocking agent selected. from the group consisting of surfactants, silicones, waxes and polysaccharides.

4\. The method of claim 1further comprising the step of spirally winding the multi-ply, creped and embossed tissue product around a core to yield a rolled tissue product.

5\. The method of claim 1wherein the first tissue web consists essentially of wood pulp fibers.

6\. The method of claim 1wherein the first tissue web has a basis weight ranging from about 10 to about 30 grams per square meter (gsm).

7\. The method of claim 1wherein the multi-ply, creped and embossed tissue product has a wet CD tensile from about 110 to about 160 g/3".

8\. The method of claim 1wherein the multi-ply, creped and embossed tissue product has a Wet/Dry Ratio from about 0.10 to about 0.15.

9\. The method of claim 1wherein the multi-ply, creped and embossed tissue product has a Durability Index from 15.0 to 18.0.

10\. The method of claim 1wherein the multi-ply, creped and embossed tissue product has a Stiffness Index from 4.0 to 6.0.

11\. The method of claim 1wherein the multi-ply, creped and embossed tissue product has a Slosh time from about 15 to about 45 seconds.

12\. The method of claim 1wherein the multi-ply, creped and embossed tissue product has a wet burst strength from 150 to 200 gf.

13\. The method of claim 1wherein the latex emulsion is applied to the first tissue web by gravure printing, spraying, flexographic printing or ink jet printing.

14\. The method of claim 1wherein the latex emulsion is applied to the first tissue web in a pattern.

15\. The method of claim 14 wherein the pattern is a continuous pattern.

16\. The method of claim 14 wherein the pattern comprises a plurality of discrete dots.

17\. The method of claim 16 wherein the density of discrete dots ranges from about 25 to about 35 dots per square inch (25.4 mm2) of tissue web surface area.

18\. The method of claim 14 wherein the pattern is a continuous reticulated pattern.

19\. The method of claim 1wherein the latex emulsion comprises a non-carboxylated latex emulsion.

20\. The method of claim 1wherein the latex emulsion comprises a carboxyl-functional latex emulsion polymer. 5 10 15 20 25 30

OFFICE ACTION:
DETAILED ACTION
Notice of Pre-AIA  or AIA  Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Specification
Applicant is reminded of the proper language and format for an abstract of the disclosure.
The abstract should be in narrative form and generally limited to a single paragraph on a separate sheet within the range of 50 to 150 words in length. The abstract should describe the disclosure sufficiently to assist readers in deciding whether there is a need for consulting the full patent text for details.
The language should be clear and concise and should not repeat information given in the title. It should avoid using phrases which can be implied, such as, “The disclosure concerns,” “The disclosure defined by this invention,” “The disclosure describes,” “Disclosed is/are,” etc.  In addition, the form and legal phraseology often used in patent claims, such as “means” and “said,” should be avoided.
The disclosure is objected to because of the following informalities: the “Related Application” section should be updated in the response of this office action.
Appropriate correction is required.
The disclosure is objected to because of the following informalities: On page 1, line 1 of the specification, there is a typo in the title, i.e., Mutli” should be changed to “Multi.”
Appropriate correction is required.
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA  as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Patent No. 11,885,073 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the scope of the claims overlaps. Note that scope of the claims of the US patent is broader and encompasses the scope of the current application and thus could be used to reject the claims of the current application.
Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 6-13 of U.S. Patent No. 11,661,707 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the method of the current application produce the tissue of US Patent, i.e., the tissue of the US Patent has all the claimed properties of the tissue made by the current application/claims and forming rolls with the claimed tissue(s) would have been obvious to one of ordinary skill in the art, since rolls are the most common way to present tissues to the consumer.
Claims 1 and 5-11 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-9 of U.S. Patent No. 11,371,191 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the method of the current application produce the tissue of US Patent, i.e., the tissue of the US Patent has all the claimed properties of the tissue made by the current application/claims.
Allowable Subject Matter
Claims 1-20 would be allowable if rewritten or amended to overcome the rejection(s) under Non-Statutory Double Patenting, set forth in this Office action.
The following is a statement of reasons for the indication of allowable subject matter:  the prior art does not teach nor fairly suggest a process of making multiply tissue products including the application of a non-crosslinked vinyl acetate-ethylene polymer to a surface of a first web/ply, creping it and then plying the creped tissue with two or more creped tissues to form a product with the claimed properties.
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure in the art of “Durable And Dispersible Creped Multi-Ply Tissue.”

APPLICANT REBUTTAL: REMARKS
I
ARGUMENTS
Claims 1-20 are presented for the Examiner's consideration. Pursuant to 37 C.F.R. 1.111, reconsideration of the present application in view of the foregoing amendments and the following remarks is respectfully requested.
I.  Amendments to the Specification
The Title has been amended to correct a typographical error.
The Abstract has been amended to address and overcome the objections raised by the Examiner and to conform with guidance set forth in the MPEP.
Applicant respectfully submits the present amendments do not constitute new matter. II.  Allowable Subject Matter
Applicant thanks the Examiner for indicating that claims 1-20 constitute allowable subject matter. Ill.  Claim Rejections
Claims 1-20 stand rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Patent No. 11,885,073 B2 and claims 6-13 of U.S. Patent No. 11,661,707 B2 and claims 1 and 5-11 of U.S. Patent No. 11,371,191 B2. Applicant is filing an electronic Terminal Disclaimer via EFS-Web contemporaneously herewith rendering this rejection moot. IV. Conclusions

NEXT OFFICE ACTION: Notice of Pre-AIA  or AIA  Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Reasons for Allowance
The following is an examiner’s statement of reasons for allowance: the prior art does not teach nor fairly suggest a process of making multiply tissue products including the application of a non-crosslinked vinyl acetate-ethylene polymer to a surface of a first web/ply, creping it and then plying the creped tissue with two or more creped tissues to form a product with the claimed properties.
Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee.  Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.”
Conclusion

CITED REFERENCE SUMMARIES: Ref US20240141593A1: Claims:
A method of manufacturing a multi-ply, creped and embossed tissue product comprising the steps of: a. providing a first tissue web having a first outer surface and a second outer surface; b. providing a heated creping surface; c. applying a latex emulsion comprising a non-crosslinked vinyl acetate-ethylene polymer to at least the first outer surface of the first tissue web to yield a latex treated tissue web; d. adhering the latex treated tissue web to the heated creping surface; e. contacting the adhered tissue web with a creping blade to remove the adhered tissue web from the heated creping surface and yield a creped tissue ply; f. conveying two or more creped tissue plies through an embossing-laminating device to yield a multi-ply, creped and embossed tissue product having a geometric mean tensile strength (GMT) from 700 to 1,700 g/3â³, a Durability Index from 10.0 to 18.0 and a Slosh time from 10 seconds to 2 minutes.
a. providing a first tissue web having a first outer surface and a second outer surface;
b. providing a heated creping surface;
c. applying a latex emulsion comprising a non-crosslinked vinyl acetate-ethylene polymer to at least the first outer surface of the first tissue web to yield a latex treated tissue web;
d. adhering the latex treated tissue web to the heated creping surface;
e. contacting the adhered tissue web with a creping blade to remove the adhered tissue web from the heated creping surface and yield a creped tissue ply;
f. conveying two or more creped tissue plies through an embossing-laminating device to yield a multi-ply, creped and embossed tissue product having a geometric mean tensile strength (GMT) from 700 to 1,700 g/3â³, a Durability Index from 10.0 to 18.0 and a Slosh time from 10 seconds to 2 minutes.
The method of claim 1 further comprising the step of applying a softening composition to the outer surface of at least one creped tissue ply, wherein the softening composition is selected from the group consisting of a polyhydroxy compound having a molecular weight of at least about 1,000 g/mol, a diamidoamine quaternary compound, an ester quaternary compound, an alkoxy alkyl quaternary compound, a benzyl quaternary compound, an alkyl quaternary compound, an imidazolinium quaternary compounds, a polysiloxane and glycerin.
The method of claim 1 wherein the latex emulsion further an anti-blocking agent selected. from the group consisting of surfactants, silicones, waxes and polysaccharides.
The method of claim 1 further comprising the step of spirally winding the multi-ply, creped and embossed tissue product around a core to yield a rolled tissue product.
The method of claim 1 wherein the first tissue web consists essentially of wood pulp fibers.
The method of claim 1 wherein the first tissue web has a basis weight ranging from about 10 to about 30 grams per square meter (gsm).
The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a wet CD tensile from about 110 to about 160 g/3â³.
The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a Wet/Dry Ratio from about 0.10 to about 0.15.
The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a Durability Index from 15.0 to 18.0.
The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a Stiffness Index from 4.0 to 6.0.
The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a Slosh time from about 15 to about 45 seconds.
The method of claim 1 wherein the multi-ply, creped and embossed tissue product has a wet burst strength from 150 to 200 gf.
The method of claim 1 wherein the latex emulsion is applied to the first tissue web by gravure printing, spraying, flexographic printing or ink jet printing.
The method of claim 1 wherein the latex emulsion is applied to the first tissue web in a pattern.
The method of claim 14 wherein the pattern is a continuous pattern.
The method of claim 14 wherein the pattern comprises a plurality of discrete dots.
The method of claim 16 wherein the density of discrete dots ranges from about 25 to about 35 dots per square inch (25.4 mm 2 ) of tissue web surface area.
The method of claim 14 wherein the pattern is a continuous reticulated pattern.
The method of claim 1 wherein the latex emulsion comprises a non-carboxylated latex emulsion.
The method of claim 1 wherein the latex emulsion comprises a carboxyl-functional latex emulsion polymer.
Ref US11885073B2: Claims:
What is claimed is: 1. A method of manufacturing a rolled tissue product comprising the steps of: a. providing a first tissue web; b. providing a heated creping surface; c. applying a non-crosslinked vinyl acetate-ethylene polymer to the first tissue web; d. adhering the first tissue web to the heated creping surface; e. removing the adhered first tissue web from the heated creping surface to yield a creped tissue ply; f. plying two or more creped tissue plies together to form a multi-ply tissue product, wherein the multi-ply tissue product has a geometric mean tensile strength (GMT) greater than about 700 g/3″, a Durability Index of about 10.0 or greater and a Slosh time less than about 2 minutes. 2. The method of claim 1 further comprising the step of applying a softening composition to the creped tissue ply or the multi-ply tissue product, wherein the softening composition is selected from the group consisting of a polyhydroxy compound having a molecular weight of at least about 1,000 g/mol, a diamidoamine quaternary compound, an ester quaternary compound, an alkoxy alkyl quaternary compound, a benzyl quaternary compound, an alkyl quaternary compound, an imidazolinium quaternary compounds, a polysiloxane and glycerin. 3. The method of claim 1 further comprising the step of applying an anti-blocking agent to the heated creping surface, wherein the anti-blocking agent is selected, from the group consisting of surfactants, silicones, waxes and polysaccharides. 4. The method of claim 1 further comprising the step of embossing the creped tissue ply. 5. The method of claim 1 further comprising the step of spirally winding the multi-ply tissue product around a core to yield a rolled tissue product. 6. The method of claim 1 wherein the first tissue web consists essentially of wood pulp fibers. 7. The method of claim 1 wherein the first tissue web has a basis weight ranging from about 10 to about 30 grams per square meter (gsm). 8. The method of claim 1 wherein the multi-ply tissue product has a GMT from about 700 to about 1,700 g/3″. 9. The method of claim 1 wherein the multi-ply tissue product has a wet CD tensile from about 110 to about 160 g/3″. 10. The method of claim 1 wherein the multi-ply tissue product has a Wet/Dry Ratio from about 0.10 to about 0.15. 11. The method of claim 1 wherein the multi-ply tissue product has a Durability Index of about 15.0 or greater. 12. The method of claim 1 wherein the multi-ply tissue product has a Stiffness Index from about 4.0 to about 6.0. 13. The method of claim 1 wherein the multi-ply tissue product has a Slosh time from about 15 to about 45 seconds and a wet burst strength from about 150 to about 200 gf. 14. The method of claim 1 wherein the step of removing the adhered first tissue web from the heated creping surface to yield a creped tissue ply is carried out by a contacting the adhered tissue web with a creping blade. 15. The method of claim 1 wherein the non-crosslinked vinyl acetate-ethylene polymer is applied to the first tissue web in a pattern. 16. The method of claim 15 wherein the pattern is a continuous pattern. 17. The method of claim 16 wherein the density of discrete dots ranges from about 25 to about 35 dots per square inch (25.4 mm2) of tissue web surface area. 18. The method of claim 15 wherein the pattern comprises a plurality of discrete dots. 19. The method of claim 15 wherein the pattern is a continuous reticulated pattern. 20. The method of claim 1 wherein the non-crosslinked vinyl acetate-ethylene polymer is applied to the first tissue web by gravure printing, spraying, flexographic printing or ink jet printing.
A method of manufacturing a rolled tissue product comprising the steps of: a. providing a first tissue web; b. providing a heated creping surface; c. applying a non-crosslinked vinyl acetate-ethylene polymer to the first tissue web; d. adhering the first tissue web to the heated creping surface; e. removing the adhered first tissue web from the heated creping surface to yield a creped tissue ply; f. plying two or more creped tissue plies together to form a multi-ply tissue product, wherein the multi-ply tissue product has a geometric mean tensile strength (GMT) greater than about 700 g/3″, a Durability Index of about 10.0 or greater and a Slosh time less than about 2 minutes.
The method of claim 1 further comprising the step of applying a softening composition to the creped tissue ply or the multi-ply tissue product, wherein the softening composition is selected from the group consisting of a polyhydroxy compound having a molecular weight of at least about 1,000 g/mol, a diamidoamine quaternary compound, an ester quaternary compound, an alkoxy alkyl quaternary compound, a benzyl quaternary compound, an alkyl quaternary compound, an imidazolinium quaternary compounds, a polysiloxane and glycerin.
The method of claim 1 further comprising the step of applying an anti-blocking agent to the heated creping surface, wherein the anti-blocking agent is selected, from the group consisting of surfactants, silicones, waxes and polysaccharides.
The method of claim 1 further comprising the step of embossing the creped tissue ply.
The method of claim 1 further comprising the step of spirally winding the multi-ply tissue product around a core to yield a rolled tissue product.
The method of claim 1 wherein the first tissue web consists essentially of wood pulp fibers.
The method of claim 1 wherein the first tissue web has a basis weight ranging from about 10 to about 30 grams per square meter (gsm).
The method of claim 1 wherein the multi-ply tissue product has a GMT from about 700 to about 1,700 g/3″.
The method of claim 1 wherein the multi-ply tissue product has a wet CD tensile from about 110 to about 160 g/3″.
The method of claim 1 wherein the multi-ply tissue product has a Wet/Dry Ratio from about 0.10 to about 0.15.
The method of claim 1 wherein the multi-ply tissue product has a Durability Index of about 15.0 or greater.
The method of claim 1 wherein the multi-ply tissue product has a Stiffness Index from about 4.0 to about 6.0.
The method of claim 1 wherein the multi-ply tissue product has a Slosh time from about 15 to about 45 seconds and a wet burst strength from about 150 to about 200 gf.
The method of claim 1 wherein the step of removing the adhered first tissue web from the heated creping surface to yield a creped tissue ply is carried out by a contacting the adhered tissue web with a creping blade.
The method of claim 1 wherein the non-crosslinked vinyl acetate-ethylene polymer is applied to the first tissue web in a pattern.
The method of claim 15 wherein the pattern is a continuous pattern.
The method of claim 16 wherein the density of discrete dots ranges from about 25 to about 35 dots per square inch (25.4 mm2) of tissue web surface area.
The method of claim 15 wherein the pattern comprises a plurality of discrete dots.
The method of claim 15 wherein the pattern is a continuous reticulated pattern.
The method of claim 1 wherein the non-crosslinked vinyl acetate-ethylene polymer is applied to the first tissue web by gravure printing, spraying, flexographic printing or ink jet printing.
Ref US11905665B2: Claims:
A durable and dispersible rolled tissue product comprising a creped single ply tissue web spirally wound about a core, the single ply web consisting of wood pulp fibers and having a first outer surface and a creping additive disposed thereon, the product having a geometric mean tensile strength (GMT) from about 700 to about 1,000 g/3″, a cross-machine direction (CD) wet tensile strength from about 100 to about 150 g/3″, a CD Wet/Dry from 0.150 to 0.200 and a Slosh time less than about 30 seconds.
The rolled tissue product of claim 1 having a Durability Index of about 14.50 or greater.
The rolled tissue product of claim 1 having a Durability Index from 14.50 to 18.0.
The rolled tissue product of claim 1 having a GM TEA greater than about 10 g·cm/cm 2 .
The rolled tissue product of claim 1 having a Stiffness Index less than about 6.5.
The rolled tissue product of claim 1 having a wet burst greater than about 100 gf.
The rolled tissue product of claim 1 having a dry burst greater than about 750 gf.
The rolled tissue product of claim 1 having a basis weight from about 45 to about 55 grams per square meter (gsm) and a sheet bulk greater than about 8.0 cubic centimeters per gram (cc/g).
A rolled tissue product comprising a spirally wound creped single ply tissue web having a first outer surface and a non-crosslinked latex polymer disposed thereon, the product having a basis weight from 45 to 55 gsm, a GMT from 700 to 1,000 g/3″, a Durability Index from about 14.50 about 18.0 and a Slosh time less than about 30 seconds.
The rolled tissue product of claim 9 having a wet CD tensile from 100 to 150 g/3″.
The rolled tissue product of claim 9 having a CD Wet/Dry from 0.150 to 0.200.
The rolled tissue product of claim 9 having a Stiffness Index less than about 6.5.
The rolled tissue product of claim 9 having a Slosh time from 10 to 30 seconds and a wet burst strength greater than about 100 gf.
A creped tissue product comprising a creped single ply tissue web having a first and a second outer surface, a creping composition consisting essentially of a non-crosslinked vinyl acetate-ethylene polymer and optionally an anti-blocking agent disposed on the first or the second outer surface, wherein the product has a GMT from 700 to 1,000 g/3″, a Durability Index of from about 14.50 about 18.0 and a Slosh time less than about 30 seconds.
The creped tissue product of claim 14 wherein the creping composition comprises an anti-blocking agent selected from the group consisting of surfactants, silicones, waxes and polysaccharides.
The creped tissue product of claim 14 having a Stiffness Index from 4.0 to 6.5.
The creped tissue product of claim 14 having a wet CD tensile from 100 to 150 g/3″.
The creped tissue product of claim 14 having a CD Wet/Dry from 0.100 to 0.200.
The creped of claim 14 having a Slosh time from 10 to 30 seconds and a wet burst strength greater than about 100 gf.
Ref US11661707B2: Claims:
A rolled tissue product comprising a spirally wound, embossed, multi-ply tissue web having a first outer surface comprising a plurality of embossments and a non-crosslinked latex polymer disposed thereon and a second outer surface comprising a non-crosslinked latex polymer disposed thereon, the product having a basis weight from about 45 to about 60 gsm, a GMT from about 700 to about 1,700 g/3″, a Stiffness Index from about 4.0 to about 6.0 and a Slosh time less than about 2 minutes.
The rolled tissue product of claim 1 having a wet CD tensile from about 110 to about 160 g/3″.
The rolled tissue product of claim 1 having a Wet/Dry Ratio from about 0.10 to about 0.15.
The rolled tissue product of claim 1 having a Durability Index of about 15.0 or greater.
The rolled tissue product of claim 1 having a Slosh time from about 15 to about 45 seconds and a wet burst strength from about 150 to about 200 gf.
A creped, multi-ply tissue product comprising: a. a first and a second tissue ply; b. a creping composition consisting essentially of a non-crosslinked vinyl acetate-ethylene polymer and optionally an anti-blocking agent disposed on the first and the second tissue ply; c. at least one softening composition selected from the group consisting of a polyhydroxy compound having a molecular weight of at least about 1,000 g/mol, a diamidoamine quaternary compound, an ester quaternary compound, an alkoxy alkyl quaternary compound, a benzyl quaternary compound, an alkyl quaternary compound, an imidazolinium quaternary compounds, a polysiloxane and glycerin disposed on the first or the second tissue ply; and d. a plurality of embossments disposed on the first or the second tissue ply, wherein the product has a GMT from about 700 to about 1,700 g/3″, a Stiffness Index from about 4.0 to about 6.0 and a Slosh time less than about 2 minutes.
a. a first and a second tissue ply;
b. a creping composition consisting essentially of a non-crosslinked vinyl acetate-ethylene polymer and optionally an anti-blocking agent disposed on the first and the second tissue ply;
c. at least one softening composition selected from the group consisting of a polyhydroxy compound having a molecular weight of at least about 1,000 g/mol, a diamidoamine quaternary compound, an ester quaternary compound, an alkoxy alkyl quaternary compound, a benzyl quaternary compound, an alkyl quaternary compound, an imidazolinium quaternary compounds, a polysiloxane and glycerin disposed on the first or the second tissue ply; and
d. a plurality of embossments disposed on the first or the second tissue ply,
wherein the product has a GMT from about 700 to about 1,700 g/3″, a Stiffness Index from about 4.0 to about 6.0 and a Slosh time less than about 2 minutes.
The creped, multi-ply tissue product of claim 6 having a Durability Index from about 10.0 to about 20.0.
The creped, multi-ply tissue product of claim 6 wherein the creping composition comprises an anti-blocking agent selected from the group consisting of surfactants, silicones, waxes and polysaccharides.
The creped, multi-ply tissue product of claim 6 wherein the vinyl acetate-ethylene polymer is carboxylated.
The creped, multi-ply tissue product of claim 6 having a wet CD tensile from about 110 to about 160 g/3″.
The creped, multi-ply tissue product of claim 6 having a Wet/Dry Ratio from about 0.10 to about 0.15.
The creped, multi-ply tissue product of claim 6 having a Durability Index from about 15.0 to about 20.0.
The creped, multi-ply tissue product of claim 6 having a Slosh time less than about 60 seconds and a wet burst strength from about 150 to about 200 gf.
Ref US11371191B2: Claims:
What is claimed is: 1. A creped, multi-ply tissue product comprising a first creped tissue ply and a second creped tissue ply, the first and second creped tissue plies comprising fibers selected from the group consisting of hardwood fibers, softwood fibers and combination thereof the product having a geometric mean tensile strength (GMT) greater than about 700 g/3″, a Stiffness Index from about 4.0 to about 6.0, a Durability Index of about 10.0 or greater and a Slosh time less than about 2 minutes. 2. The creped, multi-ply tissue product of claim 1 having a GMT from about 700 to about 1,700 g/3″. 3. The creped, multi-ply tissue product of claim 1 having a GM TEA greater than about 14.5 g·cm/cm2. 4. The creped, multi-ply tissue product of claim 1 having a GM TEA from about 20 to about 30 g·cm/cm2. 5. The creped, multi-ply tissue product of claim 1 having a TEA Index greater than about 1.50. 6. The creped, multi-ply tissue product of claim 1 having a wet burst strength of about 1,000 gf or greater. 7. The creped, multi-ply tissue product of claim 1 having a Slosh time from about 20 to about 120 seconds. 8. The creped, multi-ply tissue product of claim 1 having a basis weight from about 45 to about 60 grams per square meter (gsm) and a sheet bulk greater than about 8.0 cubic centimeters per gram (cc/g). 9. The creped, multi-ply tissue product of claim 1 having a wet CD tensile greater than about 100 g/3″. 10. The creped, multi-ply tissue product of claim 1 having a Wet/Dry Ratio from about 0.10 to about 0.15.
A creped, multi-ply tissue product comprising a first creped tissue ply and a second creped tissue ply, the first and second cre
[Truncated to input limit]